PURPOSE: Curcumin has shown a variety of biological activity for various human diseases including cancer in preclinical setting. Its poor oral bioavailability poses significant pharmacological barriers to its clinical application. Here, we established a practical nano-emulsion curcumin (NEC) containing up to 20% curcumin (w/w) and conducted the pharmacokinetics of curcuminoids and curcumin metabolites in mice. METHODS: This high loading NEC was formulated based on the high solubility of curcumin in polyethylene glycols (PEGs) and the synergistic enhancement of curcumin absorption by PEGs and Cremophor EL. The pharmacokinetics of curcuminoids and curcumin metabolites was characterized in mice using a LC-MS/MS method, and the pharmacokinetic parameters were determined using WinNonlin computer software. RESULTS: A tenfold increase in the AUC (0→24h) and more than 40-fold increase in the C (max) in mice were observed after an oral dose of NEC compared with suspension curcumin in 1% methylcellulose. The plasma pharmacokinetics of its two natural congeners, demethoxycurcumin and bisdemethoxycurcumin, and three metabolites, tetrahydrocurcumin (THC), curcumin-O-glucuronide, and curcumin-O-sulfate, was characterized for the first time in mice after an oral dose of NEC. CONCLUSION: This oral absorption enhanced NEC may provide a practical formulation to conduct the correlative study of the PK of curcuminoids and their pharmacodynamics, e.g., hypomethylation activity in vivo.
PURPOSE:Curcumin has shown a variety of biological activity for various human diseases including cancer in preclinical setting. Its poor oral bioavailability poses significant pharmacological barriers to its clinical application. Here, we established a practical nano-emulsion curcumin (NEC) containing up to 20% curcumin (w/w) and conducted the pharmacokinetics of curcuminoids and curcumin metabolites in mice. METHODS: This high loading NEC was formulated based on the high solubility of curcumin in polyethylene glycols (PEGs) and the synergistic enhancement of curcumin absorption by PEGs and Cremophor EL. The pharmacokinetics of curcuminoids and curcumin metabolites was characterized in mice using a LC-MS/MS method, and the pharmacokinetic parameters were determined using WinNonlin computer software. RESULTS: A tenfold increase in the AUC (0→24h) and more than 40-fold increase in the C (max) in mice were observed after an oral dose of NEC compared with suspension curcumin in 1% methylcellulose. The plasma pharmacokinetics of its two natural congeners, demethoxycurcumin and bisdemethoxycurcumin, and three metabolites, tetrahydrocurcumin (THC), curcumin-O-glucuronide, and curcumin-O-sulfate, was characterized for the first time in mice after an oral dose of NEC. CONCLUSION: This oral absorption enhanced NEC may provide a practical formulation to conduct the correlative study of the PK of curcuminoids and their pharmacodynamics, e.g., hypomethylation activity in vivo.
Authors: Zhongfa Liu; Zhiliang Xie; William Jones; Ryan E Pavlovicz; Shujun Liu; Jianhua Yu; Pui-kai Li; Jiayuh Lin; Jame R Fuchs; Guido Marcucci; Chenglong Li; Kenneth K Chan Journal: Bioorg Med Chem Lett Date: 2008-12-14 Impact factor: 2.823
Authors: Shaiju K Vareed; Madhuri Kakarala; Mack T Ruffin; James A Crowell; Daniel P Normolle; Zora Djuric; Dean E Brenner Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-06 Impact factor: 4.254
Authors: Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Paula B Luis; Claus Schneider; Janet L Funk Journal: J Nutr Biochem Date: 2018-10-11 Impact factor: 6.048
Authors: C C C Teixeira; L M Mendonça; M M Bergamaschi; R H C Queiroz; G E P Souza; L M G Antunes; L A P Freitas Journal: AAPS PharmSciTech Date: 2015-06-04 Impact factor: 3.246
Authors: Abu Syed Md Anisuzzaman; Abedul Haque; Mohammad Aminur Rahman; Dongsheng Wang; James R Fuchs; Selwyn Hurwitz; Yuan Liu; Gabriel Sica; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin; A R M Ruhul Amin Journal: Cancer Prev Res (Phila) Date: 2015-10-28
Authors: Emanuele P Lima; Odinei H Gonçalves; Franciele Q Ames; Lidiane V Castro-Hoshino; Fernanda V Leimann; Roberto K N Cuman; Jurandir F Comar; Ciomar A Bersani-Amado Journal: Inflammation Date: 2020-11-09 Impact factor: 4.092
Authors: Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk Journal: J Nat Prod Date: 2019-02-22 Impact factor: 4.050